Pharma 4.0 Continuous mRNA Drug Products Manufacturing †

Continuous mRNA drugs manufacturing is perceived to nurture flow processes featuring quality by design, controlled automation, real time validation, robustness, and reproducibility, pertaining to regulatory harmonization. However, the actual adaptation of the latter remains elusive, hence batch-to-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouranidis, Andreas, Davidopoulou, Christina, Tashi, Reald-Konstantinos, Kachrimanis, Kyriakos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466472/
https://www.ncbi.nlm.nih.gov/pubmed/34575447
http://dx.doi.org/10.3390/pharmaceutics13091371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466472/
https://www.ncbi.nlm.nih.gov/pubmed/34575447
http://dx.doi.org/10.3390/pharmaceutics13091371

Ejemplares similares